Suppliers / Siegfried PharmaChemikalien Minden

Siegfried PharmaChemikalien Minden

Germany Updated 9 July 2026

Siegfried PharmaChemikalien Minden is an API manufacturer based in Germany. It holds 32 active US drug master files and 18 valid CEPs across a filed portfolio of 18 molecules. Its GMP standing is certified by ZLG (DE). Its most recent recorded inspection, by US FDA, closed on 21 April 2023 as VAI.

32
active US DMFs
18
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 April 2023 VAI US FDA
  • 8 March 2019 VAI US FDA
  • 3 February 2017 NAI US FDA
  • 24 October 2014 VAI US FDA
  • 10 February 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Minden, Germany Not on file
Germany, Germany 3002807400

What they file, and where

Molecule Regulators Docs
Pseudoephedrine EDQM, SFDA (Saudi Arabia), US FDA 6
Theophylline EDQM, US FDA 6
Xylometazoline EDQM, SFDA (Saudi Arabia), US FDA 6
Ephedrine EDQM, US FDA 5
Caffeine EDQM, SFDA (Saudi Arabia), US FDA 4
Oxymetazoline EDQM, SFDA (Saudi Arabia), US FDA 4
Phenylephrine EDQM, SFDA (Saudi Arabia), US FDA 4
Tretinoin EDQM, SFDA (Saudi Arabia), US FDA 4
Dobutamine EDQM, US FDA 3
Dopamine EDQM, US FDA 3
Show all 18 molecules on file
Isotretinoin EDQM, US FDA 3
Naloxone EDQM, US FDA 3
Alitretinoin US FDA 2
Theophylline-Ethylenediamine EDQM 2
Amylmetacresol EDQM 1
Buprenorphine SFDA (Saudi Arabia) 1
Selegiline EDQM 1
Tilidine EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ZLG (DE) None 8

Comparing suppliers?

Choose your molecules and target markets. Siegfried PharmaChemikalien Minden comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 April 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates